RU97113193A -
BACILLUS ANTHRACIS 81/1 BACTERIA STRAIN USED AS A TEST INFECTING CULTURE
- Google Patents
BACILLUS ANTHRACIS 81/1 BACTERIA STRAIN USED AS A TEST INFECTING CULTURE
Info
Publication number
RU97113193A
RU97113193ARU97113193/13ARU97113193ARU97113193ARU 97113193 ARU97113193 ARU 97113193ARU 97113193/13 ARU97113193/13 ARU 97113193/13ARU 97113193 ARU97113193 ARU 97113193ARU 97113193 ARU97113193 ARU 97113193A
Ставропольский научно-исследовательский противочумный институт
Filing date
Publication date
Application filed by Ставропольский научно-исследовательский противочумный институтfiledCriticalСтавропольский научно-исследовательский противочумный институт
Priority to RU97113193ApriorityCriticalpatent/RU2141522C1/en
Priority claimed from RU97113193Aexternal-prioritypatent/RU2141522C1/en
Publication of RU97113193ApublicationCriticalpatent/RU97113193A/en
Application grantedgrantedCritical
Publication of RU2141522C1publicationCriticalpatent/RU2141522C1/en
201000009910diseases by infectious agentDiseases0.000claims1
Claims (1)
Штамм бактерий Bacillus anthracis 81/1, используемый в качестве высоковирулентной тест-заражающей культуры.The bacterial strain Bacillus anthracis 81/1, used as a highly virulent test infection culture.
RU97113193A1997-07-311997-07-31Test-infecting culture in assay of immunogenicity of anthrax vaccines, effectiveness of agents for emergency prophylaxis and treatment of patients with anthrax
RU2141522C1
(en)
Test-infecting culture in assay of immunogenicity of anthrax vaccines, effectiveness of agents for emergency prophylaxis and treatment of patients with anthrax
Test-infecting culture in assay of immunogenicity of anthrax vaccines, effectiveness of agents for emergency prophylaxis and treatment of patients with anthrax
Test-infecting culture in assay of immunogenicity of anthrax vaccines, effectiveness of agents for emergency prophylaxis and treatment of patients with anthrax
Method of screening compound having antimicrobial activity on pathogenic microorganism infecting organism having acquired immune mechanism by using organism having natural immune mechanism alone, and method of evaluating the antimicrobial activity by using organism having natural
STRAIN BACILLUS SUBTILIS TRACHES RESISTANT TO TETRACYCLIN, RIFAMPICIN, AMPICILLIN, CHLORAMPHENICOL, STREPTOMYCIN WITH ANTIBACTERIAL ACTIVITY RELATED TO RELATIONS
STRAIN BACILLUS SUBTILIS PAC RESISTANT TO RIFAMPICIN, AMPICILLIN AND STREPTOMYCIN, POSSESSING ANTIBACTERIAL ACTIVITY AGAINST PATHOGENIC TYPES OF MICROORGANISMS